Secondary metabolites play an important role in the adaptation of plants to environmental stress[@b1]. Plants react to exogenous factors such as nutrients, hormones and light through signalling pathways that induce downstream stress responses including the modulation of gene expression and the regulation of a broad range of biochemical processes, resulting in the remodelling of metabolism[@b2]. Key signalling molecules include Ca^2+^, nitrates, phosphates, 2,4-dichlorophenoxyacetic acid (2,4-D), naphthalene acetic acid (NAA), indole acetic acid (IAA), 6-benzylaminapurine (BAP), kinetin, abscisic acid (ABA), jasmonates, salicylic acid, gibberellic acid (GA~3~), ethylene, polyamines, cyclic nucleotides (cAMP and cGMP) and diacylglycerol[@b2][@b3][@b4]. The accumulation of metabolites in stressed plants may also have economic significance[@b1] because signalling components or elicitors can be used to trigger the production of secondary metabolites in whole plants or plant cell and tissue cultures[@b5].

Design of experiments (DOE) approaches are used to study the influence of multiple factors simultaneously, allowing the influence of each factor to be determined regardless of other parameters while maintaining independence between the assessment of different effects. This contrasts with the classic 'one factor at a time' approach, which is laborious, time consuming and lacks the ability to provide a global picture of molecular events[@b6]. Factorial designs have recently flourished in plant biology, where they have been used to optimize cultivation parameters for cell and tissue cultures[@b7][@b8] and to increase the yield of metabolites[@b9][@b10] or recombinant proteins[@b11] by medium optimization. However, most of these applications of DOE featured a small number of response variables when describing the corresponding system or process. A much more comprehensive multivariate strategy is needed to identify multiple inducible biomarkers in the plant metabolome following the application of diverse elicitors, so the combination of DOE and metabolomics is an attractive approach for the systematic evaluation of changes in plant secondary metabolism[@b12].

Metabolomics generates large, multi-dimensional datasets using automated analytical procedures such as gas chromatography or high-pressure liquid chromatography coupled to mass spectrometry (GC-MS and HPLC-MS). It is therefore necessary to reduce the dimensionality of the data using multivariate statistical methods. The complexity of data mining is enhanced further when the data originate from several sources (e.g. complementary chromatography systems or ionization modes) and data fusion strategies are therefore required. An additional difficulty is encountered when multiple input factors are varied simultaneously, because different sources of variation are mixed. The importance of multiple simultaneous metabolic effects has been underestimated in the past and here we addressed this challenge by combining several orthogonal techniques: reversed-phase ultra-high-pressure liquid chromatography (RP-UHPLC) with positive and negative electrospray ionization (ESI) modes, and hydrophilic interaction liquid chromatography (HILIC), both coupled to time of flight mass spectrometry (TOF-MS) to achieve greater coverage of the metabolome.

Several strategies have been developed for the simultaneous analysis of multiple datasets. The proposed data modelling approach is an extension of the multiple kernel learning method to orthogonal partial least squares discriminant analysis (OPLS-DA), i.e. consensus OPLS-DA, which combines data blocks using the weighted sum of X·X^T^ product association matrices corresponding to their linear kernel[@b13]. The OPLS-DA framework is advantageous for data interpretation because relevant metabolic variations are associated with predictive components, whereas unrelated variation is summarized in so-called orthogonal components[@b14]. In consensus OPLD-DA, the block weighting is based on modified RV-coefficients so that the Y response orientates the consensus kernel towards improved predictability. Cross-validation is carried out to assess the optimal model size and avoids overfitting, using DQ^2^ (an adaptation of the conventional Q^2^ value) for discriminant analysis[@b15].

To our knowledge, this is the first systematic investigation of metabolic remodelling in plants following simultaneous multi-factorial treatment. This novel combination of metabolomics and experimental design, associated with the simultaneous analysis of multiblock omics data, is a powerful approach that allows us to unravel the metabolic responses in transgenic tobacco cells at a global level when diverse input factors such as macronutrients, plant growth regulators and light are varied simultaneously. Furthermore, this high-throughput screening system can be used for process optimization with metabolically engineered cell lines. Herein we hypothesize that product optimization using the simultaneous exploration of multiple factors may achieve more accurate and reproducible results than the assessment of one factor at a time.

Results
=======

UHPLC-QTOF-MS fingerprinting
----------------------------

The acquisition of high-quality metabolomics data is an essential aspect of metabolic profiling because it facilitates the identification step. The UHPLC-QTOF-MS gradient conditions we applied allowed us to monitor more than 3500 features in the *m*/*z* range 100--1200 based on RP-UHPLC (ESI^+^ and ESI^−^ ion detection modes) and HILIC (ESI^+^ ion detection mode). Pareto scaling was applied as data normalization. The multiblock data fusion strategy we used allows the integration of datasets originating from different ionization (ESI^+^/ESI^−^) and separation (RP/HILIC) modes, yielding 1500, 1366 and 1368 variables for the RP/ESI^+^, RP/ESI^−^ and HILIC/ESI^+^ blocks, respectively. Some of the signals were present in all blocks, whereas others were found in only one or two data blocks and thus provided complementary information[@b13]. The target metabolites in methanol extracts, obtained from tobacco suspensions expressing *Valeriana officinalis* geraniol synthase (*VoGES*) gene, were identified based on mass fragmentation and the comparison of characteristic *m/z* species with internal or publicly accessible natural product databases.

Consensus OPLS-DA data modelling and metabolite identification
--------------------------------------------------------------

A supervised data mining approach (consensus OPLS-DA) was applied to determine the distinct metabolic changes caused by the simultaneous modulation of diverse input factors, and leave-one-out cross-validation (LOOCV) was carried out to evaluate the appropriate number of orthogonal components based on the DQ^2^ parameter. A series of 1000 permutation tests was performed for each model by randomizing the original Y class response in order to assess the statistical validity of the models[@b13].

Significant models were obtained for most of the factors with a prediction accuracy (PA) of 87--100% and a statistical significance of p \< 0.01. Lower prediction accuracy was observed for GA~3~ (PA = 62.5%, p = 0.013) and ethephon (PA = 60.4%, p = 0.015), whereas KH~2~PO~4~ (PA = 57.3%, p = 0.225) and MgSO~4~ (PA = 47.9%, p = 0.62) were found to be statistically non-significant ([Table 1](#t1){ref-type="table"}). Random permutations of the design matrix simulate data under the null hypothesis, i.e. no effect of the experimental factor under study. Because similar or higher prediction accuracies could be achieved from randomly permutated designs, we decided to omit KH~2~PO~4~ and MgSO~4~ from subsequent experiments aiming to identify metabolites and to determine their biological importance.

Next we used S-plots to highlight relevant metabolites based on their contributions to the model, reflecting both their amplitude of variation and their reliability[@b14]. This visualization method helps to identify biochemically significant metabolites based on their position in the S-plots. The ideal biomarker has a high covariance magnitude and high correlation reliability. This low risk of spurious correlations corresponds to the upper right quadrant (area 1) or lower left quadrant (area 4) of each S-plot. The biomarkers located in area 1 are associated with metabolites that become more abundant when the factor strength is enhanced or less abundant when the factor strength is reduced, i.e. an upregulation effect (metabolic levels^(+)^/factor^(+)^ or metabolic levels^(−)^/factor^(−)^). Similarly, the biomarkers in area 4 are linked to metabolites that become less abundant when the factor strength is enhanced or more abundant when the factor strength is reduced, i.e. a downregulation effect (metabolic levels^(−)^/factor^(+)^ or metabolic levels^(+)^/factor^(−)^). Because all three data blocks (RPLC NEG, RPLC POS and HILIC) are integrated in a single model for each factor, ions detected by each analytical protocol can be associated in a combined S-plot.

High-resolution QTOF-MS/MS profiling allowed 45 compounds represented by some of the most significant features with respect to the factors we investigated (i.e. they were located in areas 1 and 4 of the S-plots) to be tentatively identified, at least to the level of the compound class ([Table 2](#t2){ref-type="table"}). However, the complete identification of all other relevant metabolites remains challenging and these preliminary results may serve as a starting point for the further targeted isolation and purification of the metabolites of interest.

Simultaneous treatments reveal nutrient--metabolite and elicitor--metabolite networks
-------------------------------------------------------------------------------------

Our primary goal was to identify metabolites that respond to each factor treatment when multiple factors are modulated simultaneously. Using this approach, we avoided the restriction of experimental results caused by the artificially narrow experimental conditions of the one factor at a time approach. In the following sections, bold numbers in parentheses represent the compounds from the list of identified metabolites ([Table 2](#t2){ref-type="table"}).

Nutrients
---------

KNO~3~ treatment ([Fig. 1](#f1){ref-type="fig"}) increased the abundance of several ions representing glutamine (**8**) and scopolin (**9**), but also single ions representing a 2,4-D metabolite (**14**) (t~R~ = 8.85 min; *m/z* 559.2755) and hexosyl geranidiol (**5**) (t~R~ = 5.96 min; *m/z* 355.1749). In contrast, KNO~3~ caused the extracellular loss of potassium ions, detected as K^+^ (KHCOO)~n~ adducts (**44**), and inhibited the formation of nicotine (**45**), hydroxysphingosine (**10**) and C16:3 monoacylglycerol (**29**). Single ions representing the following compounds were also less abundant following treatment with KNO~3~: trihydroxy-C18:2 acids (**37**, **38**) (t~R~ = 11.36/11.18 min; *m/z* 327.2170/327.2171), a dihydrozeatin (DHZ) adduct (**22**) (t~R~ = 3.26 min; *m/z* 354.1794), a cyclanilide metabolite (**33**) (t~R~ = 9.26 min; *m/z* 620.0896) and BAP glycoside (**26**) (t~R~ = 4.08 min; *m/z* 388.1647).

NH~4~NO~3~ treatment ([Fig. S1](#S1){ref-type="supplementary-material"}) induced the synthesis of the monoterpenoid derivatives malonyl-hexosyl-geraniol (**4**), pentosyl-hexosyl-geraniol (**2**) and malonyl-hexosyl-geranidiol (**7**) as well as scopolin (**9**). Two single ion species representing BAP glycosides were also more abundant following treatment with NH~4~NO~3~, i.e. BAP glucoside (**26**) (t~R~ = 3.94 min; *m/z* 388.1634) and BAP riboside (**27**) (t~R~ = 6.59 min; *m/z* 358.1532), as well as a salicylic acid glucoside (**30**) (t~R~ = 3.31 min; *m/z* 323.0759). In contrast, auxin metabolites representing NAA (**18**) and 2,4-D (**14**) as well as single ions representing conjugated dihydroxy-C18:2 fatty acid (**43**) and hexosyl-hexosyl-geraniol (**6**) were less abundant following treatment with NH~4~NO~3~.

The formation of three metabolites was strongly induced by calcium treatment: hydroxysphingosine (**10**), scopolin (**9**) and hexosyl-hexosyl-geraniol (**6**). Adenosine (**11**) synthesis was also stimulated by calcium and was represented by a single ion (t~R~ = 2.65 min; *m/z* 268.1082) ([Fig. S2](#S1){ref-type="supplementary-material"}). Several metabolites became less abundant following calcium treatment, namely C16:3 monoacylglycerol (**29**), geraniol derivatives produced by the heterologous geraniol synthase (**1**, **2**, **4** and **7**), and a fatty acid with conjugated triene (**40**) (t~R~ = 12.15 min; *m/z* 325.2013).

Auxins
------

Numerous metabolites were influenced by IAA ([Fig. S3](#S1){ref-type="supplementary-material"}). We observed an increase in the abundance of indole-3-carboxylic acid glucoside (**17**) and K^+^ (**44**). The monoterpenoid derivatives pentosyl-hexosyl-geraniol (**2**) and malonyl-hexosyl-geraniol (**4**), a DHZ glycoside (**21**) (t~R~ = 6.56 min; *m/z* 384.1906) and its adduct (**22**), C16:3 monoacylglycerol (**29**) and nicotine (**45**) (t~R~ = 3.8096 min; *m/z* 163.1254) were also more abundant following treatment with IAA. The formation of other metabolites was inhibited, particularly adenosine (**11**), scopolin (**9**), BAP glucoside (**26**), and the geraniol derivatives pentosyl-hexosyl-geranidiol (**1**) (t~R~ = 5.76 min; *m/z* 487.2159), hexosyl-geranidiol (**5**) and malonyl-hexosyl-geranidiol (**6**) (t~R~ = 8.96 min; *m/z* 501.2312).

Indole-3-butyric acid (IBA) treatment ([Fig. S4](#S1){ref-type="supplementary-material"}) induced the synthesis of IBA glycoside (**20**), geraniol glycosides (**2**, **4**) and C16:3 monoacylglycerol (**29**) but caused the loss of other metabolites including geraniol derivatives (**1**, **5**, **6**).

NAA treatment ([Fig. S5](#S1){ref-type="supplementary-material"}) mainly increased the abundance of its own derivatives (**18**, **19**). The following metabolites became less abundant: several single ions characteristic of fatty acids with conjugated triene (**40**--**42**), trihydroxy-C18:2 acid (**37**), indole-3-carboxylic acid glucoside (**17**) (t~R~ = 4.68 min; *m/z* 346.0923), pentosyl-hexosyl-geraniol (**2**), malonyl-hexosyl-geraniol (**4**) and nicotine (**45**).

The formation of several compounds was induced by 2,4-D treatment ([Fig. S6](#S1){ref-type="supplementary-material"}): 2,4-D metabolites (**14**--**16**), adenosine (**11**) and the geraniol derivatives (**1**, **5**, **6**). Pentosyl-hexosyl-geraniol (**2**), malonyl-hexosyl-geraniol (**4**) and C16:3 monoacylglycerol (**29**) became less abundant.

Our observations show that naturally occurring (endogenous) auxins such as IAA and IBA upregulate (**2** and **4**) and downregulate (**1**, **5** and **6**) the synthesis of geraniol glycosides, whereas the synthetic auxins (NAA and 2,4-D) have exactly the opposite effects on these metabolites.

Cytokinins
----------

The presence of kinetin ([Fig. S7](#S1){ref-type="supplementary-material"}) strongly induced the synthesis of kinetin glucoside (**24**) and kinetin riboside (**25**), and to a lesser extent the geraniol derivatives pentosyl-hexosyl-geraniol (**2**), malonyl-hexosyl-geraniol (**4**) and malonyl-hexosyl-geranidiol (**7**) as well as trihydroxy-C18:2 acid (**37**). DHZ treatment ([Fig. S8](#S1){ref-type="supplementary-material"}) induced the formation of three derivatives: DHZ glycoside (**21**), DHZ adduct (**22**) and DHZ metabolite (**23**). BAP treatment ([Fig. S9](#S1){ref-type="supplementary-material"}) resulted in the appearance of three derivatives: BAP glucoside (**26**), BAP riboside (**27**) and BAP ribotide (**28**).

Other plant growth regulators
-----------------------------

Methyljasmonate (MeJa) treatment ([Fig. S10](#S1){ref-type="supplementary-material"}) only induced the formation of C16:3 monoacylglycerol (**29**) to a significant extent, but we also observed smaller increases in the abundance of a cyclanilide metabolite (**33**), hydroxysphingosine (**10**), nicotine (**45**), unidentified fatty acids with conjugated triene (**41**, **42**), trihydroxy-C18:2 acids (**37**, **38**), adenosine (**11**) and a 2,4-D metabolite (**14**). The only heterologous monoterpenoids induced by MeJa were pentosyl-hexosyl-geraniol (**2**) and malonyl-hexosyl-geranidiol (**7**). The formation of scopolin (**9**) was strongly inhibited, whereas the synthesis of hexosyl-hexosyl-geraniol (**6**), BAP riboside (**27**) and abscisic acid glycoside (**35**) was more weakly downregulated.

Salicylic acid treatment ([Fig. S11](#S1){ref-type="supplementary-material"}) mainly induced the formation of its polar derivatives salicylic acid glucoside (**30**) and salicylic acid dihexosyl-glucoside (**31**), but also C16:3 monoacylglycerol (**29**), trihydroxy-C18:2 acid (**38**) and the unidentified fatty acids with conjugated triene (**41**--**43**). The monoterpenoids pentosyl-hexosyl-geraniol (**2**) and malonyl-hexosyl-geraniol (**4**) were also more abundant. Salicylic acid treatment inhibited the formation of a cyclanilide metabolite (**32**), a 2,4-D metabolite (**14**), scopoletin (**12**), a scopoletin derivative (**13**), hexosyl-hexosyl-geraniol (**6**) and BAP riboside (**27**).

GA~3~ treatment ([Fig. S12](#S1){ref-type="supplementary-material"}) induced the formation of C16:3 monoacylglycerol (**29**), pentosyl-hexosyl-geranidiol (**1**), trihydroxy-C18:2 acid (**37**), BAP glucoside (**26**), adenosine (**11**), malonyl-hexosyl-geranidiol (**7**), hexosyl-geranidiol (**5**), NAA metabolites (**18**, **19**) and the unidentified fatty acid with conjugated triene (**42**). It inhibited the formation of scopolin (**9**), a 2,4-D metabolite (**14**), hexosyl-geraniol (**3**), hexosyl-hexosyl-geraniol (**6**), a DHZ adduct (**22**) and a cyclanilide metabolite (**32**).

Ethephon treatment ([Fig. S13](#S1){ref-type="supplementary-material"}) induced the formation of C16:3 monoacylglycerol (**29**), pentosyl-hexosyl-geraniol (**2**), BAP glucoside (**26**), trihydroxy-C18:2 acid (**38**), scopolin (**9**) and malonyl-hexosyl-geraniol (**4**), but inhibited the formation of a DHZ adduct (**22**), adenosine (**11**), hydroxysphingosine (**10**), hexosyl-geranidiol (**5**), hexosyl-hexosyl-geraniol (**6**) and a cyclanilide metabolite (**32**).

Cyclanilide treatment ([Fig. S14](#S1){ref-type="supplementary-material"}) induced the formation of its own metabolites (**32**--**34**) as well as one NAA metabolite (**18**), hexosyl-hexosyl-geraniol (**6**), unidentified fatty acids with conjugated triene (**40**--**42**), and trihydroxy-C18:2 acids (**37**, **38**). The formation of numerous compounds was downregulated, including pentosyl-hexosyl-geraniol (**2**), malonyl-hexosyl-geraniol (**4**), C16:3 monoacylglycerol (**29**), pentosyl-hexosyl-geranidiol (**1**), conjugated dihydroxy-C18:2 fatty acid (**43**), scopolin (**9**), scopoletin (**12**) and malonyl-hexosyl-geranidiol (**7**).

ABA treatment ([Fig. S15](#S1){ref-type="supplementary-material"}) resulted in the accumulation of ABA glycoside (**35**), an ABA metabolite (**36**) and its glycoside (**39**), trihydroxy-C18:2 acids (**37**, **38**), and to a lesser degree the unidentified fatty acids with conjugated triene (**40**--**42**), pentosyl-hexosyl-geranidiol (**1**) and malonyl-hexosyl-geranidiol (**7**). The abundance of DHZ (**22**), a 2,4-D metabolite (**14**), a cyclanilide metabolite (**32**), kinetin riboside (**25**), scopolin (**9**), and DHZ glycoside (**21**) declined in response to ABA.

Light
-----

Light was the only physical factor we included in our experimental design, and it was associated with an increase in the levels of adenosine (**11**), two unidentified fatty acids with conjugated triene (**41**, **42**), trihydroxy-C18:2 acids (**37**, **38**), malonyl-hexosyl-geranidiol (**7**), and to a lesser extent glutamine (**8**), a 2,4-D metabolite (**14**) and C16:3 monoacylglycerol (**29**). Light inhibited the production of alkaloids, i.e. scopoletin (**12**), a scopoletin derivative (**13**) and scopolin (**9**), and the monoterpenoids pentosyl-hexosyl-geraniol (**2**), hexosyl-geraniol (**3**), and malonyl-hexosyl-geraniol (**4**). A DHZ adduct (**22**) and hydroxysphingosine (**10**) were also less abundant under strong illumination ([Fig. S16](#S1){ref-type="supplementary-material"}).

Clustering
----------

Cluster analysis provided a global overview of regulation events that follow changes in the experimental factors. This approach allows the grouping of metabolites with similar ion features using a dendrogram, and a heat map summarizes the contribution of each of the factors in the context of each identified metabolite and thus enables the visualization of upregulation and downregulation in response to different treatments ([Fig. 2](#f2){ref-type="fig"}).

Both geranidiol glycosides (**1** and **5**) are located in a small cluster, whereas the third geranidiol derivative (**7**), an esterified monoglycoside, is found in a neighbouring cluster ([Fig. 2](#f2){ref-type="fig"}). The geraniol metabolites (**1** and **5**) are upregulated by 2,4-D, DHZ, GA~3~ and ABA and downregulated by NH~4~NO~3~, CaCl~2~, IAA, IBA, BAP, salicylic acid and ethephon, whereas the upregulation of compound (**7**) is related to NH~4~NO~3~, kinetin, MeJa, GA~3~, ABA, and light, and its downregulation is associated with CaCl~2~, NAA, BAP and cyclanilide. The geraniol glycosides (**2**, **3** and **4**) are located in a common larger cluster. These three metabolites are upregulated by IAA, IBA, kinetin and ethephon, but downregulated by CaCl~2~, 2,4-D, NAA and light. Compounds (**2** and **4**) are distinguished from hexosyl-geraniol (**3**) mainly by the action of NH~4~NO~3~, i.e. (**2** and **4**) are upregulated whereas (**3**) is downregulated by NH~4~NO~3~. The heat map also shows the upregulation of hexosyl-hexosyl-geraniol (**6**) by CaCl~2~, 2,4-D, BAP and cyclanilide, and its downregulation by NH~4~NO~3~, IAA, IBA, DHZ, MeJa, salicylic acid, GA~3~, ethephon and ABA.

Discussion
==========

The combination of fractional factorial design and consensus OPLS-DA methods allowed us to systematically explore the effect of multiple factors on plant metabolism, using transgenic tobacco cell cultures as a model system. This simultaneous application of treatment stress assesses all experimental factors under diverse conditions that could occur in nature. We tentatively identified 45 constituents in areas 1 and 4 of the S-plots following the fractionation and analysis of plant cell extracts by UHPLC-QTOF-MS, corresponding to metabolites whose abundance changed substantially in response to the experimental factors. These metabolites represented multiple classes of natural products: monoterpenoids, nitrogen-containing compounds, coumarins, fatty acids and their esters, and derivatives of phytohormones and plant growth regulators used as additives in the experiments.

Geraniol and its glycosides do not occur naturally in tobacco plants and their presence in our samples reflects the activity of the stably integrated *VoGES* gene[@b16]. However, the glycosylation profile of geraniol produced by our cell suspension cultures differed to that observed in whole plants. The cells produced seven distinct geraniol glycosides whereas 19 variants were produced by transgenic tobacco plants and *Nicotiana benthamiana* leaves used for transient expression. The acetylated glycosides produced at later stages of plant development were not monitored in our plant cell cultures. The cell suspension cultures produced geraniol monoglycosides and diglycosides, whereas the whole plants also produced geraniol glycosides with three or more sugar adducts. However, our cell suspension cultures accumulated geranidiol derivatives that are not produced in agroinfiltrated or transgenic plants, which instead produce geranic acid glycosides[@b16].

Nitrogenous compounds are found in tobacco cells because they have multiple core metabolic functions and are also precursors in the biosynthesis of tobacco alkaloids[@b17]. Phytoalexins defend plants against biotic and abiotic stress[@b18]. The coumarin scopoletin (**12**) is one of the phytoalexins produced in tobacco[@b19][@b20][@b21]. C16:3 monoacylglycerol (**29**) is a glyceride which can be formed by the esterification of glycerol with one fatty acid or by enzymatic hydrolysis of a fatty acid from diacylglycerol by the action of diacylglycerol lipase. Diacylglycerol acts as a signalling molecule during plant development and in response to stress tolerance, nutrient deficiency and other environmental stimuli[@b22][@b23][@b24].

Our metabolomic analysis showed that plant cells react strongly to phytohormones and plant growth regulators. Plants limit the impact of harmful xenobiotic compounds by hydroxylation, glutathione conjugation, glycosylation, malonylation and sulfonylation[@b25][@b26]. Most of the phytohormone and growth regulator derivatives we identified were polar glucosylated products, which are generally more soluble than the parent molecule thus facilitating elimination. We also detected malonylated geraniol glycosides, confirming that malonylation is one of the key mechanisms used by tobacco cells to metabolize xenobiotic compounds[@b27].

The production of glutamine was strongly upregulated by KNO~3~ treatment in our experiment. Nitrate is assimilated by plant cells from nitrite and ammonium, and is then converted into the amino acid glutamine[@b28]. The protein kinase CIPK23 is involved in both nitrate and potassium signalling[@b29]. CIPK23 phosphorylates nitrate transporter NPF6.3 after interacting with the calcineurin-B-like protein CBL9, and reduces nitrate uptake capacity in the presence of high external NO~3~^−^ concentrations, whereas the CBL1-CIPK23 and CBL9-CIPK23 complexes activate the K^+^ channel AKT1[@b30]. A monoacylglycerol derivative (**29**) was also less abundant following KNO~3~ treatment. This may be a hydrolysis product of diacylglycerol which activates protein kinase C and induces nitrate reductase gene expression[@b31].

The NO~3~^−^/NH~4~^+^ ratio in the culture medium influences the activity of auxins and cytokinins[@b32]. We observed an increase in the abundance of ions representing 2,4-D and the loss of ions representing DHZ metabolites and BAP glycoside in the KNO~3~ S-plot, but an increase in the abundance of BAP glycosides and the loss of ions representing 2,4-D and NAA metabolites in the NH~4~NO~3~ S-plot. This indicates that the balance between NO~3~^−^ and NH~4~^+^ ions may affect phytohormone sensitivity.

NH~4~NO~3~ and CaCl~2~ had the most significant impact on the biosynthesis of geraniol glycosides among the inorganic factors we tested. NH~4~NO~3~ induced the formation of geraniol glycosides (**2**, **4**, **7**) but inhibited the formation of hexosyl-hexosyl-geraniol (**6**), whereas calcium showed the opposite behaviour. Higher concentrations of useable nitrogen also enhanced the accumulation of linalool and citronellol by *Saccharomyces cerevisiae*[@b33]. Geraniol blocks calcium and potassium channels in mammalian cells[@b34] and similar cyclic nucleotide-gated ion channels are found in plants[@b35].

Ca^2+^ induced the hydroxylation of sphingosine and adenosine agreeing with previous observations that sphingosine-1-phosphate increases cytosolic free Ca^2+^ [@b36] and cyclic adenosine monophosphate regulates calcium channels in the plasma membrane of *Arabidopsis thaliana* leaf guard and mesophyll cells[@b37].

Scopolin and its 7-O-glucoside are key components of the abiotic stress response[@b18] and the abundance of both compounds increased following treatment with all three statistically significant nutrients in our study. The accumulation of scopoletin in tobacco cells and its conversion to a glucoside is also induced by 2,4-D[@b21]. Ions representing scopolin were also detected following the treatment of our cells with 2,4-D. Scopoletin synthesis was strongly inhibited by MeJa concurring with data showing that scopoletin biosynthesis induced by *Alternaria alternata* is strongly dependent on jasmonic acid but not ABA, although MeJA does not induce scopoletin production in the absence of *A. alternata*[@b38]. In our cells, the formation of scopoletin was also inhibited by GA~3~.

We detected nicotine produced in trace amounts by our transgenic tobacco cell cultures, which comprise green (photosynthesizing) cells derived from the aerial parts of the plant, although *de novo* nicotine synthesis takes place mainly in the roots[@b39]. MeJa induced nicotine production in our tobacco cells in a similar manner as previously shown for *N. attenuata*[@b39]. The downregulation of nicotine production we observed following the treatment with KNO~3~ and NAA agrees with previous reports for cultured tobacco callus, and the effect of K^+^ is probably mediated by NAA[@b40]. We also observed that nicotine biosynthesis was induced by IAA but moderately suppressed by 2,4-D[@b41]. The combined effect of MeJa, auxins and K^+^ on the regulation of nicotine synthesis suggests that multiple factors contribute to the same process.

The biosynthesis of monoterpenoid glycosides appeared to be influenced by auxins and cytokinins, perhaps reflecting the antagonistic crosstalk between these two phytohormone classes[@b42]. Our experimental results support the idea that phytohormones function in a complex network involving the different hormonal pathways but that there is also elaborate crosstalk with nutrients and elicitors. The auxin-sensitive signalling protein SHY2 is regulated by the cytokinin-induced protein ARR1 (*Arabidopsis* response regulator), which in turn is repressed by gibberellin thus connecting three hormones in one network[@b42]. This may explain why our GA~3~ S-plot contained ion traits that were also affected by auxins and cytokinins. We also observed evidence for ethylene/cytokinin and cytokinin/ABA crosstalk[@b42].

Light has a potent effect on monoterpenoid metabolism by modulating the expression of monoterpenoid synthase genes, controlling precursor synthesis, and affecting constitutive promoter activity[@b43][@b44]. Geraniol glycosides were also influenced by light in our cell cultures. Light induced the formation of malonyl-hexosyl-geranidiol (**7**) but suppressed the formation of pentosyl-hexosyl-geraniol (**2**), hexosyl-geraniol (**3**) and malonyl-hexosyl-geraniol (**4**).

We have developed a systematic approach, which implements an experimental design strategy in the context of metabolomics to account for the diverse factors applied simultaneously to plant cells. This is a valuable method for the investigation of complex environmental stress and its impact on plant metabolism by optimizing the number of experiments needed to assess the factors. Our approach significantly reduces the time and effort required for testing by using consensus OPLS-DA models to evaluate and interpret metabolic changes caused by the simultaneous application of diverse ecological factors. This systematic workflow may facilitate the discovery and characterization of factor--nutrient--elicitor networks and appropriate biomarkers. Finally, we conclude that this novel approach should be able to streamline process optimization for the reproducible production of any secondary metabolite in plant cell cultures by the simultaneous exploration of multiple factors rather than the assessment of one factor at a time.

Materials and Methods
=====================

Plant cell cultures, treatments and harvesting
----------------------------------------------

We used tobacco (*N. tabacum* cv. Samsun NN) transgenic cell suspension cultures, expressing stably *V. officinalis* geraniol synthase. The cell cultures were initiated and maintained as previously described[@b8]. Two levels (low/high) were used for each of the factors selected for analysis. The low level of each macronutrient in the plant cell culture medium was based on classical Murashige and Skoog (MS) medium[@b11][@b45] whereas the high level was based on our recent medium optimization study, although the concentrations of NH~4~NO~3~ were reversed[@b11][@b45]. The specific low/high concentrations were prepared as follows: KNO~3~ (18.79/70.16 mM), CaCl~2~ (2.99/10.84 mM), KH~2~PO~4~ (1.25/2.72 mM), MgSO~4~ (1.5/3.0 mM) and NH~4~NO~3~ (4.24/20.61 mM). For the auxins, cytokinins and plant regulators (IAA, IBA, NAA, 2,4-D, kinetin, DHZ, BAP, MeJa, salicylic acid, GA~3~, ethephon, cyclanilide and ABA) the low and high levels were set to 0 and 10 μM, respectively. Finally, the low and high levels of light were set to 11.50 and 35.62 μmol/cm^2^/s, respectively[@b8]. The factor levels are summarized in [Table S1](#S1){ref-type="supplementary-material"}.

The following cultivation conditions were used: flask volume 50 ml (Erlenmeyer glass flasks), filling volume 25 ml, inoculum size 1.4 g fresh weight (FW), triacetyl-β-cyclodextrin concentration 2 mM, and shaking frequency 180 rpm[@b8]. The plant cell suspension cultures were grown for 9 days before the cells were harvested, then filtered twice under vacuum and frozen at −20 °C. The cultures were elicited with phytohormones and plant growth regulators 6 days post-inoculation. The experiment was conducted at 26 °C with a 16-h photoperiod in an ISF1-X shaker (Kühner AG, Birsfelden, Switzerland).

Sample preparation
------------------

The samples were extracted as previously described[@b46]. Briefly, \~100-mg aliquots of plant material were mixed with methanol (1:3 w/v) in a shaker mill (TissueLyser, Retsch, Haan, Germany) and pulverized with a steel ball at 25 beats per second for 1 min. Homogenized samples were sonicated (15 min), centrifuged (1750 × *g*, 10 min, 25 °C) and supernatants were passed through a 0.2-μm membrane filter.

UHPLC-MS
--------

The samples prepared above were analysed on an Acquity UPLC system coupled to a QTOF Premier MS detector (Waters, Milford, MA, USA). For RP-UHPLC, a Waters Acquity BEH C18 column (2.1 × 150 mm, 1.7 μm) was used with water containing 0.1% (v/v) formic acid (A) and acetonitrile containing 0.1% (v/v) formic acid (B) as eluents applied as the following gradient: 0 min, 5% B; 23.5 min, 80% B; 24 min, 96% B; 26 min, 96% B. The flow rate was 0.4 ml/min with the column temperature set to 45 °C. HILIC separation was carried out using a Waters Acquity HILIC column (2.1 × 150 mm, 1.7 μm) with 33 mM aqueous ammonium formate, pH 4.5 (A) and acetonitrile (B) as eluents applied as the following gradient: 0 min, 4% A; 3 min, 4% A; 17.5 min, 32% A; 18 min, 55% A; 20 min, 55% A. The flow rate was 0.5 ml/min with the column temperature set to 50 °C.

A pool was created by adding equal volumes from all samples to serve as a QC injection. Nine QC injections in total were distributed at regular intervals in the analytical batch. An acceptable variation was achieved for all peaks, including those with the highest intensity (coefficient of variation less than 40%).

Positive and negative ESI was applied in separate analytical runs (positive only for the HILIC method) with a desolvation gas flow of 780 l/h at 400 °C, a capillary voltage of 4.5 kV and a cone voltage of 45 V. Mass spectra were acquired over the *m/z* range 100--1200 in "W mode" using leucine enkephalin as a lock mass standard.

Raw data processing
-------------------

Mass/retention time markers were extracted from the raw UHPLC-ESI-MS data using MarkerLynx XS v4.1 (Waters). The following method parameters were set: retention time window 1.6--24.6 min, *m/z* range 100--1200, XIC window 0.02 Da, peak smoothing activated, marker intensity threshold 30, mass window 0.04 Da, retention time window 0.2 min, noise elimination level 6.0, and deisotope data activated. All mass (*m/z*)/retention-time features related to the auxins, cytokinins and plant growth regulators provided as supplements in the plant cell culture media, as well as features derived from impurities in the LC eluents, were removed from the raw metabolomics datasets by removing all features detected in blank runs (solvent injection) or in analytical runs of the pure additives before data evaluation.

Experimental design
-------------------

The experimental design was based on an orthogonal array with 96 runs created with the free open-source R package DoE.base[@b47] as described in the [supplementary material](#S1){ref-type="supplementary-material"}. Given the size of this experiment, tests for effects of 2-level factors at significance level 5% can detect effects of size "one standard deviation" with about 99% power, effects of size "half a standard deviation" with about 68% power, and effects of size "0.75 standard deviations" with about 95% power. The design was optimized to screen 14 factors by keeping the confounding of low-order effects minimal: all main effects are orthogonal to each other (orthogonal array), the design was based on an array with the lowest possible number of squared canonical correlations from three-factor sets equal to 1[@b48] and the factors were accommodated on columns of the base array such that confounding between main effects and two-factor interactions, and subsequently among two-factor interactions, was minimized[@b8].

This fractional factorial design, with a randomized run order, was used to screen 12 two-level factors, one three-level factor and one four-level factor: we thus screened for the effects of light and 18 diverse substances representing macronutrients, auxins, cytokinins and elicitors. For the two-level factors, we investigated the presence of the high levels of NH~4~NO~3~, KNO~3~, CaCl~2~, KH~2~PO~4~, MgSO~4~, MeJa, salicylic acid, GA~3,~ ethephon, cyclanilide, ABA and light. For auxins (four-level factor), exactly one of IAA, IBA, NAA or 2,4-D was present, whereas for cytokinins (three-level factor), exactly one of kinetin, DHZ or BAP was present. The experimental design with 96 runs is summarized in coded values in [Table S2](#S1){ref-type="supplementary-material"}. The remaining potentially relevant confounding between main effects and two-factor interactions in terms of triples of factor comparisons are summarized in [Fig. S17](#S1){ref-type="supplementary-material"}. For each such triple, the comparison between the levels of each factor in the triple might be affected by an interaction between the other two factors (e.g. an interaction between KNO~3~ and NH~4~NO~3~ might affect the assessment of the BAP vs. DH-z comparison for cytokinins). Sceptics might argue that this possibility for confounding is a reason to refrain from using an experimental design approach in favour of only changing one factor at a time (OFAT approach). However, if two-factor interactions are indeed relevant -- as would be necessary for the experimental design approach to suffer from misleading conclusions in terms of factor level comparisons -- the conclusions from an OFAT approach are also limited in the same manner and would be valid only for the exact settings at which the other factors have been fixed. Furthermore, to achieve a reasonable amount of replication, the OFAT approach would need a much larger number of experimental runs -- e.g. 24 runs for the reference level combination (the number obtained for the four-level factor in the 96-run experiment) might be combined with 24 runs each for the other level of the 12 two-level factors (12\*24), and 24 runs each for the other levels of the three-level and the four-level factors (5\*24), resulting in a total of 18\*24 = 432 runs instead of the 96 runs in our experiment.

Data processing and analysis
----------------------------

For each experimental factor, a consensus OPLS-DA model was built to relate the experimental metabolomics data (X) to a class matrix consisting of zeros and ones, filled according to the levels of each factor (Y). The columns of the experimental design were therefore used individually as a response matrix in the context of supervised analysis. For auxins and cytokinins, a response vector was generated individually for each hormone and filled with zero when the corresponding hormone was absent, whereas a value of one indicated its presence. The consensus OPLS algorithm implements data fusion based on multiple kernel learning. The joint analysis of multiple data tables is achieved by the combination of association matrices computed for each block. Therefore, requirements in terms of memory resources and computation time are minimized without information loss even if the experimental data include a large number of signals. A block-scaling step ensures fairness between blocks by offering equal starting chances to contribute to the model. RV coefficients are then computed to build a consensus matrix and orientate the model towards better prediction performance. A common subspace is built using a kernel version of the OPLS algorithm and the optimal number of orthogonal components is estimated by cross-validation. Because systematic variations are summarized using Y-predictive and Y-orthogonal components (OPLS framework), the interpretation of the multiblock model is straightforward. Like classical multivariate methods, a consensus score plot allows the distribution of the observations to be evaluated. Because linearity is maintained, variable loadings can easily be computed for biomarker discovery. The weight of each block in the projection also allows the role of each data source to be evaluated[@b13].

The OPLS model can be summarized as follows:

where X contains the normalized metabolomic data from data block i (i ∈ \[RPPOS, RPNEG, HILICPOS\]), Y represents a 0/1 indicator variable for experimental condition j (j ∈ \[NH~4~NO~3~, KNO~3~, CaCl~2~, KH~2~PO~4~, MgSO~4~, IAA, IBA, NAA, 2,4-D, kinetin, DHZ, BAP, MeJa, salicylic acid, GA~3~, ethephon, cyclanilide, ABA, light\]), t~p~ is the Y-predictive score matrix, p~p~ is the Y-predictive loading matrix for X, t~o~ is the Y-orthogonal score matrix, p~o~ is the Y-orthogonal loading matrix for X, q~p~ is the Y-predictive loading matrix for Y, and E and F are the residual matrices for X and Y, respectively. Note that the four indicator variables for the cytokinins sum to a column of "+1" entries, as do the three indicator variables for the auxins. Consensus OPLS-DA modelling was carried out under the MATLAB^®^ v8 environment (The MathWorks, Natick, USA) with combinations of toolboxes and in-house functions, including the publicly available RV-coefficients MATLAB m-file[@b49] and the KOPLS open source package[@b50].

Cluster analysis
----------------

Subsets of metabolites sharing similar patterns were investigated using cluster analysis. For that purpose, the contribution (loading) of each ion feature associated with an identified metabolite was collected across all significant consensus OPLS-DA models and displayed in a dendrogram and a heat map. This strategy highlights upregulation and downregulation. Cluster analysis was carried out with the Bioinformatics Toolbox v4.2 under the MATLAB^®^ v8 environment (The MathWorks) using Euclidean distances and the Ward aggregation method.

Factors with more than two levels
---------------------------------

Auxins and cytokinins were two factors in our design associated with three and four levels, respectively. Exactly one auxin and one cytokinin were included in each run of the experimental design. Consequently, the four Y(j) indicator columns corresponding to auxins and the three Y(j) indicator columns corresponding to cytokinins are linearly dependent, as stated above. Our analysis included all indicator columns, because each is treated separately. This implies that downregulation or upregulation must be interpreted within the linearly-dependent groups, e.g. if the three auxins IAA, IBA and 2,4-D are identified as downregulators, the fourth (NAA) must be an upregulator (relative to the other auxins). This behaviour is clearly shown in the heat map and also implies analogous dependencies among the S-plots of the auxins and cytokinins, respectively.
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###### Performance indices of the consensus OPLS-DA models evaluated for each of the screened factors.

                    Prediction accuracy   Estimated p-value
  ---------------- --------------------- -------------------
  KNO~3~                   86.5%               \<0.001
  NH~4~NO~3~              100.0%               \<0.001
  CaCl~2~                  76.0%               \<0.001
  KH~2~PO~4~               57.3%                0.225
  MgSO~4~                  47.9%                0.62
  2,4-D                    97.9%               \<0.001
  IAA                      90.6%               \<0.001
  NAA                     100.0%               \<0.001
  IBA                      99.0%               \<0.001
  DHZ                     100.0%               \<0.001
  Kinetin                 100.0%               \<0.001
  BAP                     100.0%               \<0.001
  MeJa                     99.0%               \<0.001
  Salicylic acid           96.9%               \<0.001
  GA~3~                    62.5%                0.013
  Ethephon                 60.4%                0.015
  Cyclanilide              97.9%               \<0.001
  ABA                      93.8%               \<0.001
  Light                    97.9%               \<0.001

Prediction accuracy was evaluated by leave-one-out-cross-validation, whereas a series of 1000 permutation tests allowed an empirical p-value to be estimated.

###### List of identified metabolites.

  No.         Metabolite name                                           Characteristic *m/z*   t~R~(min)   Detection mode
  ----------- -------------------------------------------------------- ---------------------- ----------- ----------------
  **1**       **pentosyl-hexosyl-geranidiol**                                 463.2174          5.7656         RPNEG
  487.2159    5.7593                                                           RPPOS                      
  503.1882    5.7588                                                           RPPOS                      
  **2**       **pentosyl-hexosyl-geraniol**                                   447.2226          9.5952         RPPOS
  471.2209    9.5930                                                           RPPOS                      
  487.1962    9.5926                                                           RPPOS                      
  919.4505    9.6056                                                           RPNEG                      
  **3**       **hexosyl-geraniol**                                            339.1804          10.3455        RPPOS
  355.1536    10.3461                                                          RPPOS                      
  **4**       **malonyl-hexosyl-geraniol**                                    425.1792          11.2494        RPPOS
  441.1559    11.2498                                                          RPPOS                      
  **5**       **hexosyl-geranidiol**                                          355.1749          5.9561         RPPOS
  **6**       **hexosyl-hexosyl-geraniol**                                    477.2335          8.9770         RPNEG
  501.2312    8.9609                                                           RPPOS                      
  **7**       **malonyl-hexosyl-geranidiol**                                  441.1744          6.9855         RPPOS
  **8**       **glutamine**                                                   130.0498          10.6332        HILIC
  147.0752    10.6115                                                          HILIC                      
  293.1505    10.6280                                                          HILIC                      
  439.2178    10.6269                                                          HILIC                      
  585.2814    10.6283                                                          HILIC                      
  **9**       **scopolin**                                                    191.0343          3.5987         RPNEG
  193.0516    3.5994                                                           RPPOS                      
  193.0535    2.9972                                                           HILIC                      
  355.1048    3.5976                                                           RPPOS                      
  355.1061    3.0112                                                           HILIC                      
  377.0863    3.5995                                                           RPPOS                      
  399.0922    3.5982                                                           RPNEG                      
  731.1788    3.5973                                                           RPPOS                      
  **10**      **hydroxysphingosine**                                          280.266           15.0331        RPPOS
  298.2763    15.0274                                                          RPPOS                      
  298.2784    5.9910                                                           HILIC                      
  309.2069    15.0493                                                          RPNEG                      
  316.2867    15.0264                                                          RPPOS                      
  316.2884    5.9926                                                           HILIC                      
  338.2696    15.0462                                                          RPPOS                      
  382.2419    15.0422                                                          RPPOS                      
  **11**      **adenosine**                                                   136.0569          2.5932         HILIC
  268.1082    2.6470                                                           HILIC                      
  535.2012    2.6454                                                           HILIC                      
  **12**      **scopoletin**                                                  176.008           5.5960         RPNEG
  178.0277    5.5921                                                           RPPOS                      
  191.0344    5.5952                                                           RPNEG                      
  193.0452    5.5936                                                           RPPOS                      
  **13**      **scopoletin derivative**                                       104.0255          5.5948         RPNEG
  120.021     5.5951                                                           RPNEG                      
  133.0287    5.5925                                                           RPPOS                      
  137.0604    5.5922                                                           RPPOS                      
  148.0156    5.5950                                                           RPNEG                      
  165.0563    5.5930                                                           RPPOS                      
  215.0347    5.5938                                                           RPPOS                      
  292.9786    5.5956                                                           RPPOS                      
  300.0546    5.5893                                                           RPPOS                      
  308.0433    5.5902                                                           RPPOS                      
  316.0304    5.5889                                                           RPPOS                      
  324.0529    5.5906                                                           RPPOS                      
  383.0782    5.5973                                                           RPPOS                      
  405.0578    5.5928                                                           RPNEG                      
  405.06      5.6036                                                           RPPOS                      
  423.9898    5.5906                                                           RPPOS                      
  439.0089    5.5932                                                           RPNEG                      
  439.0133    5.5951                                                           RPPOS                      
  629.0385    5.5924                                                           RPNEG                      
  820.0741    5.5947                                                           RPNEG                      
  **14**      **metabolite of 2,4-D (1)**                                     160.9559          8.8354         RPNEG
  164.9515    8.8336                                                           RPNEG                      
  170.0464    8.8283                                                           RPPOS                      
  174.9733    8.8281                                                           RPPOS                      
  185.0569    8.8349                                                           RPNEG                      
  347.0196    8.8379                                                           RPNEG                      
  349.0374    8.8264                                                           RPPOS                      
  351.0158    8.8342                                                           RPNEG                      
  375.0145    8.8278                                                           RPPOS                      
  415.0057    8.8394                                                           RPNEG                      
  559.2755    8.8471                                                           RPNEG                      
  583.2731    8.8317                                                           RPPOS                      
  717.0307    8.8341                                                           RPNEG                      
  719.0288    8.8327                                                           RPNEG                      
  907.3045    8.8428                                                           RPNEG                      
  **15**      **metabolite of 2,4-D (2)**                                     124.9799          11.6718        RPNEG
  163.9575    11.6759                                                          RPNEG                      
  164.951     11.6753                                                          RPNEG                      
  402.9077    11.6770                                                          RPNEG                      
  404.9042    11.6725                                                          RPNEG                      
  460.9137    11.6742                                                          RPNEG                      
  **16**      **metabolite of 2,4-D (3)**                                     170.0482          7.3887         HILIC
  174.9755    7.3879                                                           HILIC                      
  349.0398    7.3867                                                           HILIC                      
  **17**      **indole-3-carboxylic acid glucoside**                          118.0649          4.6888         RPPOS
  262.0714    4.6832                                                           RPNEG                      
  322.0927    4.6813                                                           RPNEG                      
  346.0923    4.6828                                                           RPPOS                      
  669.1911    4.6807                                                           RPPOS                      
  **18**      **metabolite of NAA (1)**                                       105.0175          5.8475         HILIC
  108.0443    5.8300                                                           HILIC                      
  109.0283    5.8394                                                           HILIC                      
  117.0192    5.8314                                                           HILIC                      
  127.0403    5.8528                                                           HILIC                      
  141.0702    9.1835                                                           RPNEG                      
  141.0725    5.8253                                                           HILIC                      
  145.0526    5.8169                                                           HILIC                      
  159.0322    5.8371                                                           HILIC                      
  167.0494    9.1845                                                           RPNEG                      
  181.0659    9.1840                                                           RPNEG                      
  199.0765    9.1833                                                           RPNEG                      
  204.107     5.8286                                                           HILIC                      
  209.06      9.1827                                                           RPNEG                      
  227.0711    9.1826                                                           RPNEG                      
  230.0709    5.8179                                                           HILIC                      
  231.0554    5.8478                                                           HILIC                      
  248.0818    5.8441                                                           HILIC                      
  249.0667    5.8482                                                           HILIC                      
  266.0926    5.8349                                                           HILIC                      
  271.0456    9.1705                                                           RPPOS                      
  339.1097    9.1620                                                           RPPOS                      
  413.1212    9.1701                                                           RPPOS                      
  452.1573    5.8402                                                           HILIC                      
  457.1119    9.1727                                                           RPPOS                      
  457.1131    5.8504                                                           HILIC                      
  473.0864    5.8473                                                           HILIC                      
  473.0876    9.1693                                                           RPPOS                      
  480.188     5.8748                                                           HILIC                      
  794.2701    5.8362                                                           HILIC                      
  815.3345    9.1788                                                           RPNEG                      
  867.2371    9.1825                                                           RPNEG                      
  886.2783    5.8310                                                           HILIC                      
  889.2184    9.1827                                                           RPNEG                      
  **19**      **metabolite of NAA (2)**                                       101.023           7.9271         RPNEG
  131.0338    7.9234                                                           RPNEG                      
  132.0298    7.9449                                                           RPNEG                      
  141.0704    7.9282                                                           RPNEG                      
  141.0706    7.9397                                                           RPPOS                      
  161.0452    2.1990                                                           RPNEG                      
  185.0612    7.9236                                                           RPNEG                      
  209.0611    7.9270                                                           RPNEG                      
  221.0668    7.9282                                                           RPNEG                      
  263.0772    7.9266                                                           RPNEG                      
  300.0866    7.9416                                                           RPNEG                      
  324.0873    7.9409                                                           RPPOS                      
  389.1215    7.9262                                                           RPNEG                      
  551.1765    7.9259                                                           RPNEG                      
  614.2078    7.9002                                                           HILIC                      
  619.1631    7.9120                                                           RPPOS                      
  623.1633    7.9484                                                           RPNEG                      
  635.1373    7.9012                                                           HILIC                      
  918.244     7.9416                                                           RPNEG                      
  1191.3449   7.9262                                                           RPNEG                      
  **20**      **IBA glycoside**                                               364.1395          6.4291         RPNEG
  386.1211    6.4297                                                           RPNEG                      
  388.1387    6.4199                                                           RPPOS                      
  **21**      **glycoside of DHZ**                                            222.138           6.5705         HILIC
  382.1723    2.2985                                                           RPNEG                      
  384.1896    2.2933                                                           RPPOS                      
  384.1906    6.1062                                                           HILIC                      
  384.1906    6.5631                                                           HILIC                      
  422.1449    6.5183                                                           HILIC                      
  **22**      **DHZ adduct**                                                  220.1198          3.2585         RPNEG
  222.1346    3.2604                                                           RPPOS                      
  354.1794    3.2625                                                           RPPOS                      
  354.1807    2.3623                                                           HILIC                      
  398.1679    3.2561                                                           RPNEG                      
  **23**      **DHZ metabolite**                                              148.0651          3.7100         HILIC
  222.1377    3.7152                                                           HILIC                      
  **24**      **kinetin glucoside**                                           214.0732          2.7567         RPNEG
  216.09      2.7568                                                           RPPOS                      
  216.0905    4.0422                                                           HILIC                      
  376.1252    2.7571                                                           RPNEG                      
  378.1424    2.7578                                                           RPPOS                      
  378.1442    4.0310                                                           HILIC                      
  **25**      **kinetin riboside**                                            216.0891          5.0179         RPPOS
  346.1149    5.0193                                                           RPNEG                      
  348.1326    5.0207                                                           RPPOS                      
  **26**      **BAP glucoside**                                               224.0928          3.9369         RPNEG
  226.107     4.0927                                                           HILIC                      
  226.1073    3.9362                                                           RPPOS                      
  386.1458    3.9367                                                           RPNEG                      
  388.1634    3.9383                                                           RPPOS                      
  388.1647    4.0897                                                           HILIC                      
  410.1452    3.9378                                                           RPPOS                      
  454.1317    3.9345                                                           RPNEG                      
  631.2459    4.0379                                                           HILIC                      
  773.3008    3.9366                                                           RPNEG                      
  775.3158    4.0637                                                           HILIC                      
  **27**      **BAP riboside**                                                224.0935          6.5916         RPNEG
  226.1085    6.5889                                                           RPPOS                      
  356.1355    6.5914                                                           RPNEG                      
  358.1532    6.5893                                                           RPPOS                      
  402.1407    6.5909                                                           RPNEG                      
  **28**      **BAP ribotide**                                                438.1187          4.1593         RPPOS
  598.1542    4.1559                                                           RPNEG                      
  **29**      **C16:3 monoacylglycerol**                                      325.2295          9.2430         RPPOS
  325.2318    7.0100                                                           HILIC                      
  **30**      **salicylic acid glucoside**                                    121.0281          3.3077         RPPOS
  137.0229    3.3048                                                           RPNEG                      
  185.0448    3.3072                                                           RPPOS                      
  257.1397    3.3079                                                           RPPOS                      
  299.0764    3.3034                                                           RPNEG                      
  301.0316    3.3041                                                           RPPOS                      
  323.0759    3.3067                                                           RPPOS                      
  599.1603    3.3049                                                           RPNEG                      
  621.1426    3.3023                                                           RPNEG                      
  637.1167    3.3054                                                           RPNEG                      
  653.0792    3.3044                                                           RPNEG                      
  943.2115    3.3038                                                           RPNEG                      
  **31**      **salicylic acid, dihexosyl-glucoside**                         137.0238          3.7150         RPNEG
  485.1274    3.7172                                                           RPPOS                      
  **32**      **cyclanilide metabolite (1)**                                  177.0566          9.3597         RPPOS
  321.0997    9.3597                                                           RPPOS                      
  339.1095    9.3596                                                           RPPOS                      
  934.1961    9.3783                                                           RPNEG                      
  958.1897    9.3600                                                           RPPOS                      
  **33**      **cyclanilide metabolite (2)**                                  153.0191          9.2740         RPNEG
  159.973     9.2749                                                           RPNEG                      
  161.9896    9.2591                                                           RPPOS                      
  179.056     9.2728                                                           RPNEG                      
  187.9678    9.2742                                                           RPNEG                      
  213.0404    9.2755                                                           RPNEG                      
  227.9976    9.2761                                                           RPNEG                      
  255.9955    9.2588                                                           RPPOS                      
  263.0773    9.2750                                                           RPNEG                      
  271.9874    9.2746                                                           RPNEG                      
  275.9838    9.2753                                                           RPNEG                      
  313.9993    9.2750                                                           RPNEG                      
  347.0969    9.2584                                                           RPPOS                      
  357.0818    9.2749                                                           RPNEG                      
  476.0503    9.2743                                                           RPNEG                      
  498.0332    9.2736                                                           RPNEG                      
  527.2492    9.4612                                                           RPNEG                      
  596.0928    9.2734                                                           RPNEG                      
  618.0751    9.2752                                                           RPNEG                      
  620.0896    9.2595                                                           RPPOS                      
  **34**      **cyclanilide metabolite (3)**                                  159.9712          14.1734        RPNEG
  566.9654    14.1686                                                          RPNEG                      
  568.9623    14.1689                                                          RPNEG                      
  **35**      **ABA glycoside**                                               153.0915          6.2662         RPNEG
  425.1808    6.2678                                                           RPNEG                      
  449.1792    6.2491                                                           RPPOS                      
  **36**      **ABA metabolite**                                              139.076           4.4449         RPNEG
  279.1236    4.4451                                                           RPNEG                      
  303.1176    4.4479                                                           RPNEG                      
  465.1742    4.4411                                                           RPPOS                      
  **37**      **trihydroxy-C18:2 acid (1)**                                   327.217           11.3581        RPNEG
  **38**      **trihydroxy-C18:2 acid (2)**                                   327.2171          11.1797        RPNEG
  **39**      **glycoside of abscisic acid metabolite**                       281.1393          3.1053         RPNEG
  467.1902    3.0957                                                           RPPOS                      
  **40**      **unidentified fatty acid with conjugatedtriene (1)**           325.2013          12.1543        RPNEG
  **41**      **unidentified fatty acid with conjugated triene (2)**          325.2012          10.1746        RPNEG
  **42**      **unidentified fatty acid with conjugated triene (3)**          325.2011          9.9604         RPNEG
  **43**      **dihydroxy-C18:2 fatty acid (conjugated)**                     311.222           13.3326        RPNEG
  **44**      **potassium ion**                                               122.9253          8.4619         HILIC
  206.8899    8.4611                                                           HILIC                      
  290.8524    8.4597                                                           HILIC                      
  458.7723    8.4606                                                           HILIC                      
  542.7322    8.4597                                                           HILIC                      
  878.5772    8.4627                                                           HILIC                      
  **45**      **nicotine**                                                    106.0650          3.7917         HILIC
  120.0816    3.8033                                                           HILIC                      
  163.1254    3.8096                                                           HILIC                      
